This statistic shows the distribution of the immuno-oncology pipeline as of April 2018, by mechanism of action. At that moment, over *** immunotherapies for cancer were in the pipeline of which ** percent had PD-1/PD-L1 inhibitor/modulators as the mechanism of action.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
IQVIA. (May 28, 2018). Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved August 01, 2026, from /statistics/937599/immuno-oncology-pipeline-by-mechanism-of-action-worldwide/
IQVIA. "Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action." Chart. May 28, 2018. ÌÇÐÄÆƽâ°æ. Accessed August 01, 2026. /statistics/937599/immuno-oncology-pipeline-by-mechanism-of-action-worldwide/
IQVIA. (2018). Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: August 01, 2026. /statistics/937599/immuno-oncology-pipeline-by-mechanism-of-action-worldwide/
IQVIA. "Distribution of The Immuno-oncology Pipeline Worldwide as of 2018, by Mechanism of Action." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 28 May 2018, /statistics/937599/immuno-oncology-pipeline-by-mechanism-of-action-worldwide/
IQVIA, Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action ÌÇÐÄÆƽâ°æ, /statistics/937599/immuno-oncology-pipeline-by-mechanism-of-action-worldwide/ (last visited August 01, 2026)
Distribution of the immuno-oncology pipeline worldwide as of 2018, by mechanism of action [Graph], IQVIA, May 28, 2018. [Online]. Available: /statistics/937599/immuno-oncology-pipeline-by-mechanism-of-action-worldwide/
